Judge concludes that the FDA “acted arbitrarily and capriciously” in treating tagatose, a non-glycemic, non-cariogenic, rare sugar, differently to fellow sweetener allulose on US food labels.
Blue Tree uses ultrafiltration coupled with adsorption to selectively remove disaccharides such as sucrose, lactose, and maltose from natural beverages such as juice, milk, and beer.
Bonumose has patented a low-cost production method it claims could catapult rare sugar tagatose from a niche to a mainstream sweetener.
Incredo Sugar is structured in such a way that human taste receptors perceive it to be sweeter than a comparable amount of sugar in free unassociated form, enabling sugar reductions of 30-70%.
Blue Tree Technologies has developed a patented process to selectively remove sugars from juice, milk, and beer.
The startup’s enzymatic technology converts up to 80% of the sugars in juice into dietary fibers and non-digestible sugars without impacting the vitamins, minerals and organic acids in the final product.
An Israeli startup has emerged from stealth with patent-pending technology it claims could slash production costs for allulose, a sweetener many formulators regard as the best all-round sugar replacer, but which currently comes with a hefty price tag.
DouxMatok, the Israeli firm behind patented technology that makes sugar taste sweeter, has rebranded as Incredo and raised $30 million in a series C round to expand its sugar reduction platform.
Sweegen secures FEMA GRAS status for the sweet protein brazzein via precision fermentation; Conagen says the same tech can produce the vivid red pigment carminic acid (without crushing insects).
‘Feed the gut, protect the liver, support the brain…’ AFN caught up with sugar’s arch nemesis Dr. Robert Lustig to learn more about his three-pronged strategy to re-engineer ultra-processed foods to improve their ‘metabolic matrix’
While investor sentiment has soured on alternative proteins, last month’s Future Food Tech summit in San Francisco attracted a record number of foodtech startups showcasing everything from foodie chatbots to upcycled prebiotic fibers.
[Disclosure: AFN’s parent company, AgFunder, is an investor in The Supplant Company. Scroll down to watch our video interview with founder and CEO Dr. Tom Simmons
The San Francisco-based company will use the Series A funds to grow its team and further develop its “proprietary” food preparation platform.
The Singaporean startup wants to tackle Asia’s ‘fast-growing diabetes epidemic’ with its specialty ingredients that counter the ill effects of refined carbohydrates.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first